Abstract
Obesity is a disease with an acknowledged high metabolic and cardiovascular risk, however, only recent studies demonstrated that the dietary treatment of obesity consisting of lifestyle modification programs may be successful in the long run. As for any therapeutic procedure, the dietary hypocaloric treatment of obesity has results and objectives to be verified and surveillance is needed as far as it concerns safety and tolerability. The epidemic of obesity is spreading to impressive levels in the western world; therefore, the treatment of obesity must be cost-effective in order to reach as much people is possible, even for the aspects relative to the follow-up. Unfortunately, there are not significant official guidelines at this regard. In this article, we report the procedures of follow-up as presented in the recent long-term clinical trials that demonstrated the efficacy of the treatment of obesity. Recent patent related to the field are also discussed.
Keywords: Obesity, lifestyle intervention, efficacy, tolerability, safety, clinical trials
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: The Follow-Up of Dietary Treatment of Obesity
Volume: 2 Issue: 2
Author(s): Silvio Buscemi and Salvatore Verga
Affiliation:
Keywords: Obesity, lifestyle intervention, efficacy, tolerability, safety, clinical trials
Abstract: Obesity is a disease with an acknowledged high metabolic and cardiovascular risk, however, only recent studies demonstrated that the dietary treatment of obesity consisting of lifestyle modification programs may be successful in the long run. As for any therapeutic procedure, the dietary hypocaloric treatment of obesity has results and objectives to be verified and surveillance is needed as far as it concerns safety and tolerability. The epidemic of obesity is spreading to impressive levels in the western world; therefore, the treatment of obesity must be cost-effective in order to reach as much people is possible, even for the aspects relative to the follow-up. Unfortunately, there are not significant official guidelines at this regard. In this article, we report the procedures of follow-up as presented in the recent long-term clinical trials that demonstrated the efficacy of the treatment of obesity. Recent patent related to the field are also discussed.
Export Options
About this article
Cite this article as:
Buscemi Silvio and Verga Salvatore, The Follow-Up of Dietary Treatment of Obesity, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2008; 2(2) . https://dx.doi.org/10.2174/187221408784534240
DOI https://dx.doi.org/10.2174/187221408784534240 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Current Topics in Medicinal Chemistry Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
Current Pharmaceutical Design Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Nutritional Aspects Relating to the Developmental Origins of Health and Disease
Current Women`s Health Reviews Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews Homocysteine-Lowering Treatment in Coronary Heart Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Improvement in Hypertension Management with Pharmacological and Non- Pharmacological Approaches: Current Perspectives
Current Pharmaceutical Design The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology A Diabetes Treatment Strategy to Reduce the Risk of Cardiovascular Events: Clinical Benefits and Potential of Linagliptin
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Proteomics and Mass Spectrometry: What Have We Learned About The Heart?
Current Cardiology Reviews Mediterranean Diet and Low-grade Subclinical Inflammation: The Moli-sani Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Hemodynamic Monitoring in the Acute Management of Pediatric Heart Failure
Current Cardiology Reviews Synthetic Cannabinoids as Drugs of Abuse
Current Drug Abuse Reviews Plasma Glucose Concentrations and Cardiac Hypertrophy in Essential Hypertension
Current Hypertension Reviews Early Vascular Aging: A New Target for Hypertension Treatment
Current Pharmaceutical Design Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Current Rheumatology Reviews Synthesis and Bioactivities of 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors
Medicinal Chemistry Heat Shock Proteins - Two Sides of a Coin
Current Cardiology Reviews Combination Therapy of Statins with Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Comparative Study of Nutritional and Phytochemical Attributes of Andrographis paniculata, Bryophyllum pinnatum and Clitoria ternatea for Nutraceutical Applications
Current Nutrition & Food Science